Long-term survival and post-hoc analysis of toripalimab plus definitive chemoradiotherapy for oesophageal squamous cell carcinoma: insights from the EC-CRT-001 phase II trial
-
Published:2024-09
Issue:
Volume:75
Page:102806
-
ISSN:2589-5370
-
Container-title:eClinicalMedicine
-
language:en
-
Short-container-title:eClinicalMedicine
Author:
Wang Ruixi,
Ling Yihong,
Chen Baoqing,
Zhu Yujia,
Hu Yonghong,
Liu Mengzhong,
Yang Yadi,
Zhang Li,
Lv Yingxin,
Liu Shiliang,
Li QiaoqiaoORCID,
Xi MianORCID